EGFR-Mutated NSCLC: Treatment Options Following Progression on Osimertinib

Ticiana Leal, MD, gives a comprehensive overview of treatment options for patients with EGFR-mutated NSCLC who progress on osimertinib therapy.

Related Keywords

,Treatment Options Following Progression ,Non Small Cell Lung Cancer ,Nsclc ,Osimertinib ,Mechanism Of Resistance ,Nsclc Treatment ,Non Small Cell Lung Cancer Treatment ,Chemotherapy ,Egfr ,Mitki ,Bevacizumab ,Immunotherapy ,